.
.
.

.
gelfand noted the impact on hdl may be balanced by the improvement seen in markers of
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
©2018 citizen digital. all rights reserved
.